Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 7.5% in the morning session after the company ...

Shares of Charles River Laboratories International Inc. advanced 9.06% to $163.36 Tuesday, on what proved to be an all-around ...

This was the stock's second consecutive day of losses.

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Charles River ...

Wall Street ended higher on Friday, capping off a strong week that saw both the Nasdaq Composite and S&P 500 finish the week ...

The Trump administration’s lighter regulatory touch is spurring more corporate bosses to rev up potential dealmaking, he says ...

IQVIA (IQV) stock and Medpace (MEDP) stock soar, sending their pees such as Charles River (CRL) higher as the duo beat the consensus with Q2 results. Read more here.

The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene ...

The global Healthcare Analytical Testing Services Market, valued at US$6.33 billion in 2024 stood at US$7.48 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, ...

Those moves follow a second straight day concluding at a high for the S&P 500, which inched up 0.06% in the session. Tuesday ...

Cell models are replacing animal testing in pharma. Explore expert tips on transitioning to more accurate, ethical and ...